Oric Pharmaceuticals, Inc. (ORIC)
CIK 1796280 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Oric Pharmaceuticals, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Aug 28, 2026 | 4 | 0001695028-26-000006 |
| Aug 26, 2026 | 144 | 0001968582-26-000883 |
| Aug 3, 2026 | 10-Q | 0001193125-26-330631 |
| Aug 3, 2026 | 8-K | 0001193125-26-330568 |
| Jul 30, 2026 | S-8 | 0001193125-26-326363 |
| Jul 30, 2026 | 8-K | 0001193125-26-326309 |
| Jul 28, 2026 | 4 | 0001584759-26-000015 |
| Jul 8, 2026 | 4 | 0001584759-26-000012 |
| Jul 6, 2026 | 144 | 0001968582-26-000699 |
| Jul 6, 2026 | 144 | 0001968582-26-000698 |
| Jun 22, 2026 | 8-K | 0001193125-26-277511 |
| May 15, 2026 | SCHEDULE 13G/A | 0000905148-26-002430 |
| May 15, 2026 | SCHEDULE 13G/A | 0001738048-26-000058 |
| May 15, 2026 | SCHEDULE 13G | 0000080255-26-000420 |
| May 15, 2026 | SCHEDULE 13G/A | 0000919574-26-003469 |
| May 12, 2026 | SCHEDULE 13G/A | 0000078003-26-000067 |
| May 4, 2026 | 8-K | 0001193125-26-203993 |
| May 4, 2026 | 10-Q | 0001193125-26-204047 |
| Apr 28, 2026 | DEFA14A | 0001193125-26-186921 |
| Apr 28, 2026 | ARS | 0001193125-26-186947 |
| Apr 28, 2026 | DEF 14A | 0001193125-26-186911 |
| Mar 31, 2026 | 8-K | 0001193125-26-134618 |
| Feb 26, 2026 | 4 | 0001695028-26-000004 |
| Feb 24, 2026 | 144 | 0001968582-26-000149 |
| Feb 23, 2026 | 8-K | 0001193125-26-063974 |